Asthma Management Guidelines

Introduction to Asthma Treatment

The American Academy of Family Physicians recommends inhaled corticosteroids (ICS) as the preferred first-line controller medication for persistent asthma due to their superior effectiveness in improving asthma control compared to any other single long-term control medication 1, 2
For patients with persistent asthma, daily low-dose ICS is the preferred first-line controller treatment, as recommended by the American Academy of Family Physicians and the Journal of Allergy and Clinical Immunology 1, 2, 3

For intermittent asthma, the Journal of Allergy and Clinical Immunology recommends PRN short-acting beta-agonists (SABA) as needed for symptom relief 3
Alternative options for mild persistent asthma include leukotriene receptor antagonists (LTRA), which may be considered as a second-line option with good compliance rates, as suggested by the American Academy of Family Physicians 1, 2
The Journal of Allergy and Clinical Immunology recommends cromolyn, nedocromil, zileuton, or theophylline (with PRN SABA) as additional alternative options 3

If asthma symptoms remain uncontrolled on low-dose ICS, the Journal of Allergy and Clinical Immunology recommends adding long-acting beta-agonist (LABA) to low-dose ICS or increasing to medium-dose ICS 3, 2
For patients ≥12 years old, the American Academy of Family Physicians prefers adding LABA to ICS over increasing ICS dose alone 1, 2
The Journal of Allergy and Clinical Immunology suggests considering daily and PRN low-dose ICS-formoterol combination 3
For Step 4, the Journal of Allergy and Clinical Immunology recommends medium-dose ICS-LABA combination or adding long-acting muscarinic antagonist (LAMA) 3
For Step 5-6, the Journal of Allergy and Clinical Immunology recommends high-dose ICS-LABA combinations with consideration of biologics for severe asthma 3

The American Academy of Family Physicians indicates that increasing use of SABA more than twice weekly or more than two nights monthly suggests inadequate control and the need to initiate or intensify anti-inflammatory therapy 1, 2
The American Academy of Family Physicians recommends that ICS consistently improve asthma symptoms more effectively than any other single long-term control medication when used regularly 1, 2

The American Academy of Family Physicians warns that LABA should never be used as monotherapy for asthma due to increased risk of exacerbations and mortality 1, 2
The American Academy of Family Physicians advises against using LABA as monotherapy for asthma control due to increased risk of exacerbations and mortality 2
The American Academy of Family Physicians recommends not delaying initiation of ICS therapy in persistent asthma, as early intervention improves outcomes, and not confusing intermittent with persistent asthma - patients using SABA more than twice weekly likely need controller therapy 1, 2

The American Academy of Family Physicians recommends oral systemic corticosteroids for moderate to severe asthma exacerbations 1, 2
The Journal of Allergy and Clinical Immunology suggests considering subcutaneous immunotherapy as adjunctive treatment for patients with allergic asthma and controlled symptoms 3

The American Academy of Family Physicians recommends low-dose inhaled corticosteroids (ICS) as the preferred first-line controller medication for patients with mild persistent asthma, with a dosage of fluticasone 100 mcg, budesonide 200 mcg, or equivalent daily 4
For patients with intermittent asthma, the American Academy of Family Physicians suggests using a short-acting beta-agonist (SABA) as needed for symptom relief, with no daily controller medication required 4
The American Academy of Family Physicians recommends using a combination of ICS and long-acting beta-agonists (LABA) for patients with moderate-to-severe asthma, with a preferred dosage of fluticasone 250 mcg + salmeterol 50 mcg twice daily 4
For children 4-11 years with mild persistent asthma, the American Academy of Family Physicians recommends using lower ICS doses, such as budesonide 200 mcg daily 4

The Journal of Allergy and Clinical Immunology recommends increasing SABA use for immediate relief during exacerbations, and using a short course of oral corticosteroids for moderate-to-severe exacerbations 5
The Journal of Allergy and Clinical Immunology suggests that doubling ICS dose is not effective for exacerbation management, and instead recommends using a short course of oral corticosteroids 5

The American Academy of Family Physicians recommends scheduling follow-up every 2-4 weeks after initiating therapy, then every 1-3 months once controlled, and using spirometry at initial assessment and every 1-2 years after stabilization 4
The American Academy of Family Physicians suggests stepping up therapy if uncontrolled after 2 weeks, and stepping down when stable to find the minimum effective dose 4

The American Academy of Family Physicians recommends annual influenza vaccination for all patients with persistent asthma 4
The Journal of Allergy and Clinical Immunology identifies high-risk patients requiring intensive monitoring, including those with previous intubation or ICU admission for asthma, ≥2 hospitalizations or >3 ED visits in the past year, using >2 canisters SABA monthly, or difficulty perceiving airflow obstruction 5